BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6997347)

  • 1. Adenosine deaminase activity in peripheral lymphocytes of psoriasis and Sézary's syndrome: possible significance in T-lymphocyte dysfunction.
    Iizuka H; Koizumi H; Kimura T; Miura Y
    J Dermatol; 1980 Jun; 7(3):165-9. PubMed ID: 6997347
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of adenosine deaminase activity in neoplastics T-cells.
    Okamura J; Ikuno Y; Tasaka H; Mitsui T; Kikuchi M
    Lancet; 1980 Aug; 2(8192):486-7. PubMed ID: 6106135
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenosine deaminase activity in lymphoid subpopulations and leukemias.
    Simpkins H; Stanton A; Davis BH
    Cancer Res; 1981 Aug; 41(8):3107-10. PubMed ID: 6972803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase activity in chronic lymphocytic leukemia: evaluation of lymphocytic ADA during and after treatment.
    Liso V; Specchia G; Pavone V; Garribba P; Riezzo A; Ferrannini A
    Haematologica; 1983; 68(4):487-94. PubMed ID: 6414899
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenosine deaminase in human epidermis from healthy and psoriatic subjects.
    Koizumi H; Iizuka H; Aoyagi T; Miura Y
    Arch Dermatol Res; 1983; 275(5):310-4. PubMed ID: 6660902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human adenosine deaminase. Properties and turnover in cultured T and B lymphoblasts.
    Daddona PE
    J Biol Chem; 1981 Dec; 256(23):12496-501. PubMed ID: 6975278
    [No Abstract]   [Full Text] [Related]  

  • 7. 5'Nucleotidase and adenosine deaminase activities in human lymphocytes and lymphoblastoid cell lines.
    Dornand J; Bonnafous JC; Favero J; Gartner A; Mani JC
    Adv Exp Med Biol; 1984; 165 Pt B():261-6. PubMed ID: 6326503
    [No Abstract]   [Full Text] [Related]  

  • 8. Terminal deoxynucleotidyl transferase and adenosine deaminase in human lymphoblastoid cell lines.
    Coleman MS; Hutton JJ
    Exp Cell Res; 1975 Sep; 94(2):440-2. PubMed ID: 1081454
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell surface adenosine deaminase (ADA) and its complexing protein (ADCP) in human T-lymphoid cells.
    Dinjens WN; van der Boon J; ten Kate J; Zeijlemaker WP; De Bruijn CH; Bosman FT; Khan PM
    Adv Exp Med Biol; 1986; 195 Pt B():407-14. PubMed ID: 3532703
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased lymphocyte adenosine deaminase activity in tumor patients.
    Uberti J; Johnson RM; Talley R; Lightbody JJ
    Cancer Res; 1976 Jun; 36(6):2046-7. PubMed ID: 1268856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased adenosine deaminase activity in peripheral lymphocytes from tumor patients with metastasis.
    Galanti B; Russo M; Apice G; Giancane R
    Boll Ist Sieroter Milan; 1980 May; 59(2):138-42. PubMed ID: 7459019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine deaminase activity of normal lymphocytes and leukemic cells.
    Ben-Bassat I; Simoni F; Holtzman F; Ramot B
    Isr J Med Sci; 1979 Nov; 15(11):925-7. PubMed ID: 118945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of adenosine deaminase with differentiation of normal and leukemic T and B lymphocytes.
    Chechik BE; Schrader WP; Fernandes B; Sengupta S; Gelfand EW
    Ann N Y Acad Sci; 1985; 451():169-79. PubMed ID: 3935026
    [No Abstract]   [Full Text] [Related]  

  • 14. Roles of alternative synthetic and catabolic purine pathways in T lymphocyte differentiation.
    Cohen A; Barankiewicz J; Gelfand EW
    Ann N Y Acad Sci; 1985; 451():26-33. PubMed ID: 3000256
    [No Abstract]   [Full Text] [Related]  

  • 15. Selectively increased adenosine deaminase levels in T cells during typhoid fever.
    Nardiello S; Russo M; Pizzella T; Galanti B
    J Clin Lab Immunol; 1984 Jun; 14(2):103-5. PubMed ID: 6611417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts. Biochemical markers in lymphoid malignancy.
    Blatt J; Reaman G; Poplack DG
    N Engl J Med; 1980 Oct; 303(16):918-22. PubMed ID: 6251368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adenosine deaminase: biochemical characteristics and clinical significance of an enzyme key to cellular immunity].
    Sorribas Vivas A; Blanco Vaca F; Gómez Gerique JA; González Sastre F
    Med Clin (Barc); 1988 Apr; 90(13):548-52. PubMed ID: 3292863
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient stimulatory adenosine deaminase activity in peripheral lymphocyte lysates from a case of T-cell lymphoma.
    Kedar A; Tritsch GL; Freeman AI
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):153-62. PubMed ID: 6893085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide-metabolizing enzymes and lymphocyte differentiation.
    Barton RW; Goldschneider I
    Mol Cell Biochem; 1979 Dec; 28(1-3):135-47. PubMed ID: 231199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes.
    Ganeshaguru K; Lee N; Llewellin P; Prentice HG; Hoffbrand AV; Catovsky D; Habeshaw JA; Robinson J; Greaves MF
    Leuk Res; 1981; 5(3):215-22. PubMed ID: 6973675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.